MEDIFAST INC (MED) Stock Price, Quote, News and Overview
NYSE:MED - New York Stock Exchange, Inc. - US58470H1014 - Common Stock - Currency: USD
MED Quote, Performance and Key Statistics
14.73
+0.4 (+2.79%)
The current stock price of MED is 14.73 USD. In the past month the price decreased by -5.39%. In the past year, price decreased by -63.83%.
MED Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UL | UNILEVER PLC-SPONSORED ADR | 23.29 | 138.82B | ||
| HLN | HALEON PLC-ADR | 23.44 | 45.58B | ||
| KVUE | KENVUE INC | 20.46 | 44.71B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 30.3 | 25.83B | ||
| BRBR | BELLRING BRANDS INC | 35.08 | 9.36B | ||
| COTY | COTY INC-CL A | 20.39 | 4.98B | ||
| IPAR | INTERPARFUMS INC | 28.81 | 4.30B | ||
| ELF | ELF BEAUTY INC | 23.86 | 4.23B | ||
| ODD | ODDITY TECH LTD-CL A | 22.92 | 2.51B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 10.64 | 1.50B | ||
| OLPX | OLAPLEX HOLDINGS INC | 10.92 | 941.35M | ||
| HLF | HERBALIFE LTD | 4.24 | 837.56M |
Related stock screener links
About MED
Company Profile
Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Baltimore, Maryland and currently employs 634 full-time employees. The firm provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
Company Info
MEDIFAST INC
100 International Drive, 18th Floor
Baltimore MARYLAND 21202 US
CEO: Daniel R. Chard
Employees: 634
Company Website: https://medifastinc.com/
Investor Relations: https://ir.medifastinc.com
Phone: 14105818042
MEDIFAST INC / MED FAQ
What is the stock price of MEDIFAST INC today?
The current stock price of MED is 14.73 USD. The price increased by 2.79% in the last trading session.
What is the ticker symbol for MEDIFAST INC stock?
The exchange symbol of MEDIFAST INC is MED and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is MED stock listed?
MED stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for MEDIFAST INC stock?
9 analysts have analysed MED and the average price target is 16.83 USD. This implies a price increase of 14.26% is expected in the next year compared to the current price of 14.73. Check the MEDIFAST INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MEDIFAST INC worth?
MEDIFAST INC (MED) has a market capitalization of 161.15M USD. This makes MED a Micro Cap stock.
How many employees does MEDIFAST INC have?
MEDIFAST INC (MED) currently has 634 employees.
What are the support and resistance levels for MEDIFAST INC (MED) stock?
MEDIFAST INC (MED) has a resistance level at 15.47. Check the full technical report for a detailed analysis of MED support and resistance levels.
Is MEDIFAST INC (MED) expected to grow?
The Revenue of MEDIFAST INC (MED) is expected to decline by -14.7% in the next year. Check the estimates tab for more information on the MED EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MEDIFAST INC (MED) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MED, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MED, evaluating the profitability, health, valuation and growth aspects
- MEDIFAST INC (MED) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MEDIFAST INC (MED) Sales and EPS estimates to see what analysts future expectations are.
- MEDIFAST INC (MED) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MEDIFAST INC (MED) Insider and Institutional Ownership to learn about the owners and their transactions.
- MEDIFAST INC (MED) Stock Chart to make your own analysis
- MEDIFAST INC (MED) Latest news and press-releases to stay up to date.
Does MEDIFAST INC (MED) stock pay dividends?
MEDIFAST INC (MED) has a dividend yield of 9.97%. The yearly dividend amount is currently 6.7. Check the full fundamental report for a detailed analysis of MED dividend history, reliability and sustainability.
When does MEDIFAST INC (MED) report earnings?
MEDIFAST INC (MED) will report earnings on 2025-04-28, after the market close.
What is the Price/Earnings (PE) ratio of MEDIFAST INC (MED)?
The PE ratio for MEDIFAST INC (MED) is 7.26. This is based on the reported non-GAAP earnings per share of 2.03 and the current share price of 14.73 USD. Check the full fundamental report for a full analysis of the valuation metrics for MED.
What is the Short Interest ratio of MEDIFAST INC (MED) stock?
The outstanding short interest for MEDIFAST INC (MED) is 12.89% of its float. Check the ownership tab for more information on the MED short interest.
MED Technical Analysis
MED Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to MED. MED has an excellent financial health rating, but there are some minor concerns on its profitability.
MED Financial Highlights
Over the last trailing twelve months MED reported a non-GAAP Earnings per Share(EPS) of 2.03. The EPS decreased by -77.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.09% | ||
| ROA | 2.52% | ||
| ROE | 3.53% | ||
| Debt/Equity | 0 |
MED Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 47% to MED. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -85.07% and a revenue growth -14.7% for MED